Bevacizumab for Refractory Gastrointestinal Bleeding in Rendu-Osler-Weber Disease

Bevacizumab for Refractory Gastrointestinal Bleeding in Rendu-Osler-Weber Disease

Rendu-Osler-Weber disease, also known as hereditary hemorrhagic telangiectasia, is a rare autosomal dominant disorder which is often characterized by recurrent epistaxis, mucocutaneous and gastrointestinal telangiectasias, and visceral arteriovenous malformations. Patients with gastrointestinal invo...

Full description

Bibliographic Details
Main Authors: Carlos Bernardes, Sara Santos, Rafaela Loureiro, Verónica Borges, Gonçalo Ramos
Format: Article
Language:English
Published: Karger Publishers 2017-10-01
Series:GE: Portuguese Journal of Gastroenterology
Subjects:
Bevacizumab
Rendu-Osler-Weber disease
Hereditary hemorrhagic telangiectasia
Telangiectasias
Angiodysplasias
Gastrointestinal bleeding
Online Access:https://www.karger.com/Article/FullText/481289

Internet

https://www.karger.com/Article/FullText/481289

Similar Items